Vtv Therapeutics Inc. (VTVT)

Trade VTVT now with
12/21/2017 3:02:52 AM VTv Enters Licensing Agreement With Huadong Pharmaceutical To Rights For GLP-1r Agonist Diabetes Program In China
9/7/2017 7:25:39 AM VTv Therapeutics Announces Additional Analysis From Phase 2 Clinical Study Of TTP273
9/6/2017 7:12:31 AM JDRF And VTv Therapeutics Announce Collaboration On Phase 2 Study Of Novel Treatment For Type 1 Diabetes
8/17/2017 7:24:59 AM Race For A New Alzheimer's Drug
6/1/2017 7:09:19 AM VTv Therapeutics Completes Enrollment For Phase 3 Placebo-controlled Trial, STEADFAST
9/7/2016 7:13:49 AM VTv Closes Enrollment Of Part A Of Pivotal Phase 3 Trial Evaluating Azeliragon
8/16/2016 7:04:56 AM VTv Therapeutics Completes Enrollment Of Phase 2 Trial Evaluating TTP273 For Treatment Of Type 2 Diabetes
8/10/2016 7:07:38 AM VTv Announces Positive Initial Topline Results From Phase 2b Study Of Glucokinase Activator TTP399 In Type 2 Diabetes
7/14/2016 9:07:27 AM VTv Therapeutics Announces Phase 2b Azeliragon Data Selected For Oral Presentation